Atlas Trials

Study of AMG531(Romiplostim) in Patients With Aplastic Anemia

Clinical trial NCT03957694 · COMPLETED

Trial details

NCT number
NCT03957694
Sponsor
Kyowa Kirin Co., Ltd.
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Aplastic Anemia
Start date
2019-04-25
Primary completion
2020-11-05
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.